Hopes for fewer deaths, lower costs with genetics guiding dosing Media release 14 January 2013 Pages: 1 - 1
The US FDA is removing the boxed warning relating to liver injury from the labels of Letairis [ambrisentan] tablets, News item 14 January 2013 Pages: 2 - 2
The US FDA has announced that topiramate [Topamax] use in pregnant women has been linked to an increased chance of oral cleft News item 14 January 2013 Pages: 2 - 2
Risk of some birth defects increased with opioid exposure Clinical study 14 January 2013 Pages: 4 - 4